Last updated on March 2020

Study to Assess Safety Tolerability Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies


Brief description of study

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary antitumor activity of AZD4573 in subjects with relapsed or refractory haematological malignancies

Clinical Study Identifier: NCT03263637

Find a site near you

Start Over

Research Site

Heidelberg, Germany
  Connect »

Research Site

Amsterdam, Netherlands
  Connect »

Research Site

Nieuwegein, Netherlands
  Connect »

Research Site

Cardiff, United Kingdom
  Connect »

Research Site

Leicester, United Kingdom
  Connect »

Research Site

Manchester, United Kingdom
  Connect »

Research Site

Plymouth, United Kingdom
  Connect »

Research Site

Southampton, United Kingdom
  Connect »

Research Site

Sutton, United Kingdom
  Connect »

Research Site

London, United Kingdom
  Connect »

Research Site

Nottingham, United Kingdom
  Connect »

Research Site

Oxford, United Kingdom
  Connect »